UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________________
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION
OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934.
__________________________
Commission File Number: 001-13738
__________________________
PSYCHEMEDICS CORPORATION
(Exact name of registrant as specified in its charter)
__________________________
5220 Spring Valley Road, Suite 230
Dallas, Texas
(800) 527-7424
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
__________________________
Common Stock, par value $0.005 per share
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
| Rule 12g-4(a)(1) | ☐ | |
| Rule 12g-4(a)(2) | ☐ | |
| Rule 12h-3(b)(1)(i) | ☐ | |
| Rule 12h-3(b)(1)(ii) | ☐ | |
| Rule 15d-6 | ☒ | |
| Rule 15d-22(b) | ☐ |
Approximate number of holders of record as of the certification or notice date: 47.
Pursuant to the requirements of the Securities Exchange Act of 1934, Psychemedics Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date: January 2, 2025
| PSYCHEMEDICS CORPORATION | ||
| By: | /s/ Brian Hullinger | |
| Name: Brian Hullinger | ||
| Title: President and Chief Executive Officer | ||